According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...

For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

Two major studies challenge long-standing practices. The first shows active monitoring might safely replace surgery for some ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, ...

A new study, published in the New England Journal of Medicine, examines whether removing lymph nodes is always necessary in ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...

Ductal carcinoma in situ, or DCIS, accounts for up to 25% of diagnosed breast cancers and affects more than 50,000 women each year, according to the American Cancer Society. Often called “stage-zero ...

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...

Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer ...